Eric Decloedt

2.4k total citations
85 papers, 1.3k citations indexed

About

Eric Decloedt is a scholar working on Infectious Diseases, Virology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Eric Decloedt has authored 85 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Infectious Diseases, 20 papers in Virology and 20 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Eric Decloedt's work include HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (20 papers) and Pharmacological Effects and Toxicity Studies (15 papers). Eric Decloedt is often cited by papers focused on HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (20 papers) and Pharmacological Effects and Toxicity Studies (15 papers). Eric Decloedt collaborates with scholars based in South Africa, United States and United Kingdom. Eric Decloedt's co-authors include Gary Maartens, Jean B. Nachega, Helen McIlleron, Dan J. Stein, Edward J. Mills, John A. Joska, Peter J. Smith, Karen Cohen, Bernd Rosenkranz and Monica Gandhi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Eric Decloedt

74 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Decloedt South Africa 19 659 318 272 243 149 85 1.3k
Natella Rakhmanina United States 21 836 1.3× 351 1.1× 281 1.0× 338 1.4× 48 0.3× 95 1.3k
Jessica Cusato Italy 27 1.1k 1.6× 263 0.8× 560 2.1× 305 1.3× 163 1.1× 164 2.6k
Kimberly K. Scarsi United States 25 1.1k 1.7× 432 1.4× 526 1.9× 286 1.2× 27 0.2× 91 1.8k
Yechiel A. Hekster Netherlands 29 753 1.1× 481 1.5× 257 0.9× 790 3.3× 50 0.3× 73 2.7k
Déborah Hirt France 24 689 1.0× 269 0.8× 407 1.5× 419 1.7× 147 1.0× 93 1.8k
Afroza Akhter Australia 23 326 0.5× 41 0.1× 264 1.0× 172 0.7× 76 0.5× 71 1.8k
Roberto Muga Spain 24 595 0.9× 267 0.8× 1.2k 4.5× 303 1.2× 45 0.3× 128 2.3k
James B Cutrell United States 11 1.4k 2.2× 64 0.2× 193 0.7× 38 0.2× 81 0.5× 31 2.1k
Laura Dickinson United Kingdom 19 662 1.0× 374 1.2× 163 0.6× 191 0.8× 14 0.1× 68 999
Michelle Foisy Canada 20 455 0.7× 125 0.4× 291 1.1× 162 0.7× 10 0.1× 49 1.1k

Countries citing papers authored by Eric Decloedt

Since Specialization
Citations

This map shows the geographic impact of Eric Decloedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Decloedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Decloedt more than expected).

Fields of papers citing papers by Eric Decloedt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Decloedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Decloedt. The network helps show where Eric Decloedt may publish in the future.

Co-authorship network of co-authors of Eric Decloedt

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Decloedt. A scholar is included among the top collaborators of Eric Decloedt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Decloedt. Eric Decloedt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zyl, Gert U. van, Eric Decloedt, Lauren Jennings, et al.. (2025). A Real-Time Urine Tenofovir Assay Improves Drug Adherence Among People With HIV With Prior Virologic Failure in a Randomized Controlled Trial. Clinical Infectious Diseases. 81(5). e352–e359.
3.
Decloedt, Eric, et al.. (2025). Sertraline use in pregnancy and placental transfer: A pharmacokinetic prospective cohort study. SHILAP Revista de lepidopterología. 1(5).
4.
Decloedt, Eric, et al.. (2024). The management and clinical outcome of paracetamol poisoning in South African adults: A single-centre retrospective review. South African Medical Journal. 114(12). e1986–e1986.
5.
Bekker, Adrie, et al.. (2024). Brief Report: Can a Fraction of the Dolutegravir Dispersible Tablet Solution be Used to Dose Neonates?. JAIDS Journal of Acquired Immune Deficiency Syndromes. 96(4). 376–379. 1 indexed citations
6.
Meyer, David, et al.. (2024). The Ocular Penetration and Intraocular Pressure Lowering Effect of Topical Acetaminophen in the New Zealand White Rabbit. Journal of Ocular Pharmacology and Therapeutics. 40(8). 513–523.
7.
Decloedt, Eric, Henrik Zetterberg, Magnus Gisslén, et al.. (2023). Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial. Journal of NeuroVirology. 29(2). 156–166. 3 indexed citations
8.
Brownfoot, Fiona, et al.. (2023). An LC-MS/MS method for the simultaneous quantitation of sulfasalazine and sulfapyridine in human placenta. Journal of Pharmaceutical and Biomedical Analysis. 235. 115633–115633. 3 indexed citations
9.
10.
Decloedt, Eric, Catherine Cluver, Nicole Hunfeld, et al.. (2022). Population pharmacokinetics of esomeprazole in patients with preterm preeclampsia. British Journal of Clinical Pharmacology. 88(10). 4639–4645. 2 indexed citations
11.
Moolla, Muhammad, Andrew Whitelaw, Eric Decloedt, Coenraad F.N. Koegelenberg, & Arifa Parker. (2021). Opportunities to enhance antibiotic stewardship: colistin use and outcomes in a low-resource setting. JAC-Antimicrobial Resistance. 3(4). dlab169–dlab169. 4 indexed citations
12.
Nachega, Jean B., Nathan Kapata, Nadia A. Sam‐Agudu, et al.. (2021). Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa. International Journal of Infectious Diseases. 113. S16–S21. 44 indexed citations
13.
Jennings, Lauren, Matthew A. Spinelli, Marije Van Schalkwyk, et al.. (2021). Drug Resistance, Rather than Low Tenofovir Levels in Blood or Urine, Is Associated with Tenofovir, Emtricitabine, and Efavirenz Failure in Resource-Limited Settings. AIDS Research and Human Retroviruses. 38(6). 455–462. 15 indexed citations
14.
Allwood, Brian, Coenraad F.N. Koegelenberg, Elvis M. Irusen, et al.. (2020). Clinical evolution, management and outcomes of patients with COVID-19 admitted at Tygerberg Hospital, Cape Town, South Africa: a research protocol. BMJ Open. 10(8). e039455–e039455. 8 indexed citations
15.
Cluver, Catherine, Natalie J. Hannan, Richard Hiscock, et al.. (2018). Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial. American Journal of Obstetrics and Gynecology. 219(4). 388.e1–388.e17. 68 indexed citations
16.
Lesosky, Maia, John A. Joska, & Eric Decloedt. (2017). Simulating therapeutic drug monitoring results for dose individualisation to maintain investigator blinding in a randomised controlled trial. Trials. 18(1). 261–261. 1 indexed citations
17.
Jones, Erika, Maia Lesosky, Sandra Castel, et al.. (2017). Therapeutic drug monitoring of amlodipine and the Z-FHL/HHL ratio: Adherence tools in patients referred for apparent treatment-resistant hypertension. South African Medical Journal. 107(10). 887–887. 7 indexed citations
18.
Decloedt, Eric & Gary Maartens. (2011). Drug induced kidney disease. CME/Continuing medical education. 29(6). 252–255. 3 indexed citations
19.
Decloedt, Eric. (2011). Drug-induced renal injury : main article. 29(6). 252–255.
20.
Decloedt, Eric & Gary Maartens. (2011). Drug-induced renal injury: The kidney plays an important role in the elimination of many drugs and their metabolites. CME/Continuing medical education. 29(6). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natella Rakhmanina Breakdown of academic impact, for papers by Jessica Cusato Breakdown of academic impact, for papers by Kimberly K. Scarsi Breakdown of academic impact, for papers by Yechiel A. Hekster Breakdown of academic impact, for papers by Déborah Hirt Breakdown of academic impact, for papers by Afroza Akhter Breakdown of academic impact, for papers by Roberto Muga Breakdown of academic impact, for papers by James B Cutrell Breakdown of academic impact, for papers by Laura Dickinson Breakdown of academic impact, for papers by Michelle Foisy
Rankless by CCL
2026